BRAXF Stock Price, Chart, Stats & News

Braxia Scientific Corp.
Save
Braxia Scientific Corp. (BRAXF) does not currently pay a dividend.
28,328
Market cap
–
Current P/E
–
Forward P/E
BRAXF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively engaged in discovering and bringing to market novel pharmaceutical compounds and innovative delivery methods. Leveraging its intellectual property development platform, Braxia Scientific innovates by developing derivatives of ketamine and psilocybin, in addition to other psychedelic substances.
Similar securities
Based on sector and market capitalization
Report issue





